Upload
diegocherri
View
220
Download
0
Embed Size (px)
Citation preview
7/31/2019 Beyond Sadness Powerpoint
1/12
DepressionThere are at least two sides toevery story.
7/31/2019 Beyond Sadness Powerpoint
2/12
Depression. Its not only a state of mind.
Reference: Adapted from
American Psychiatric Association.Diagnostic and Statistical Manual of Mental Disorders.Fourth Edition,Text Revision. Washington, DC; American Psychiatric Association. 2000:345-356,489.
The symptoms of depression
Emotional Symptoms Include:
Sadness
Loss of interest or pleasure
Overwhelmed
Anxiety
Diminished ability to think orconcentrate, indecisiveness
Excessive or inappropriate guilt
Physical Symptoms Include:
Vague aches and pains
Headache
Sleep disturbances
Fatigue
Back pain
Significant change in appetiteresulting in weight loss or gain
7/31/2019 Beyond Sadness Powerpoint
3/12
Reference:
1. Simon GE, et al.N Engl J Med. 1999;341(18):1329-1335.
Depression the physical presentation
In primary care, physical symptoms are often
the chief complaint in depressed patients
N = 1146 Primary care patients with major depression
In a New England Journal of Medicine
study, 69% of diagnosed depressedpatients reported unexplained physicalsymptoms as their chief compliant1
7/31/2019 Beyond Sadness Powerpoint
4/12
Adapted from
1.Silverstein B.Am J Psychiatry. 1999;156(3):480-482.2.Silverstein B. Am J Psychiatry. 2002;159(6):1051-1052.
25%
17%
58%
37%
55%
38%35%
28%
0
10
20
30
40
50
60
70
Aches/Pain
(Women)
Aches/Pain
(Men)
Anxiety Disorder
(Women)
Anxiety Disorder
(Men)
%
ofDepressedP
atients
National ComorbiditySurvey
NIMH EpidemiologyStudy
Aches/pain a physical symptom of significance
Aches/Pain as common as anxiety among depressed patients
7/31/2019 Beyond Sadness Powerpoint
5/12
76% of compliant depressedpatients with lingeringsymptoms of depressionrelapsed within 10 months1*
The importance of emotional and physical symptoms
*Psychiatric inpatients and outpatients.
Reference:1. Adapted from: Paykel ES, et al.Psychol Med. 1995;25:1171-1180.
94% of depressedpatients who experiencedlingering symptoms hadmild to moderatephysical symptoms1
7/31/2019 Beyond Sadness Powerpoint
6/12
Serotonin5HT and NorepinephrineNE in the brain
Limbic System
Locus Ceruleus(NE Source)
PrefrontalCortex
Raphe Nuclei(5-HT source)
Cooper JR, Bloom FE. The Biochemical Basis of Neuropharmacology. 1996.
7/31/2019 Beyond Sadness Powerpoint
7/12
There are at least two sides to the neurotransmitter story
Sex
Appetite
Aggression
Concentration
Interest
Motivation
DepressedMood
Anxiety
Irritability
Thoughtprocess
References:
1. Adapted from: Stahl SM. In: Essential Psychopharmacology:
Neuroscientific Basis and Practical Applications: 2nd
ed. CambridgeUniversity Press 2000.
2. Blier P, et al.J Psychiatry Neurosci. 2001;26(1):37-43.
3. Doraiswamy PM.J Clin Psychiatry. 2001;62(suppl 12):30-35.4. Verma S, et al.Int Rev Psychiatry. 2000;12:103-114.
Norepinephrine (NE)
Both serotonin and norepinephrine mediate a broad spectrumof depressive symptoms
Serotonin (5-HT)
Vague Achesand pain
Functional domains of Serotonin and Norepinephrine1-4
7/31/2019 Beyond Sadness Powerpoint
8/12
The neurotransmitter pathway story
Adapted from References:
1. Stahl SM.J. Clin Psych. 2002;63:203-220.
2. Verma S, et al.Int Rev Psychiatry. 2000;12:103-114.
3. Blier P, et al.J Psychiatry Neurosci. 2001;26(1):37-43.
Dysregulation of Serotonin (5HT)and Norepinephrine (NE) in the brainare strongly associated withdepression
Dysregulation of 5HT and NE in thespinal cord may explain anincreased pain perception amongdepressed patients1-3
Imbalances of 5HT and NE may
explain the presence of bothemotional and physical symptoms ofdepression.
Its not all in your head
Descending Pathway
AscendingPathway
AscendingPathway
DescendingPathway
7/31/2019 Beyond Sadness Powerpoint
9/12
Depression: Current treatment outcomes1
Up to 70% of depressed patients respond ( 50%decrease in HAM-D score) to treatment but fail toachieve remission from their emotional and physicalsymptoms1*
Approximately 30% of depressed patients achieveremission ( 7 score on the HAM-D) with treatment1*
References:
1. OReardon JR, et al.PsychiatrAnn. 1998;28:633-640.
* Antidepressant clinical drug trials.
7/31/2019 Beyond Sadness Powerpoint
10/12
Response and Remission defined
Hamilton Depression Rating Scale (HAM-D): 17 Items, Total Score 0 - 52
15
7
Response
50% reduction from baseline HAM-Dscore
Remission: HAM-D Score 7
Depression
(Major Depressive Disorder)
References:
1. Frank E. Conceptualization and rationale for consensus definition terms in MDD, Arch Gen Psych. 1991; 48:851-855.
HAM-D17
Scores
7/31/2019 Beyond Sadness Powerpoint
11/12
Study in chronic depressed patients
*p .05 vs nonresponse. **p .05 vs response.
Miller IW, et al. J Clin Psychiatry. 1998;59(11):608-619.
Normal(n=482)
Remission(n=202)
Response(n=122)
Nonresponse(n=299)
Soci
alAdjustmentScale-S
R
(MeanS
D)
***
*
1
2
3
5
Treatment outcome:Effect on work & social functioning
Higher Scoreindicates greater
impairment
Remitted patients virtually equaled healthy controls onfunctioning levels at endpoint of 12-week treatment trial
(Responders & non-responders did not)
7/31/2019 Beyond Sadness Powerpoint
12/12
Many depressed patients are still depressed.
References:
1. Nierenberg AA, et al.J Clin Psychiatry. 1999:60(suppl 22):7-11.
2. OReardon JR, et al.PsychiatrAnn. 1998;28:633-640.
3. Lynch ME.J Psychiatry Neurosci. 2001;26(1):30-36.
Depressed patients continue to have needs that are not being fully addressed1
Depressed patients present with emotional and physicalsymptoms.
Approximately 30% of depressed patients achieveremission in clinical trials2*
Up to 70% of patients who respond fail to remit2*
Incomplete relief from symptoms may increase the riskof relapse2,3
Lingering emotional and physical symptoms mayjeopardize achieving remission.
*In antidepressant clinical drug trials.